Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions.
about
Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addictionIntermittent access to sweet high-fat liquid induces increased palatability and motivation to consume in a rat model of binge consumption.Reinforcing efficacy of fat, as assessed by progressive ratio responding, depends upon availability not amount consumed.Assessing binge eating. An analysis of data previously collected in bingeing rats.Dopamine and binge eating behaviorsMemantine reduces consumption of highly palatable food in a rat model of binge eatingCan We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference BehaviorFeeding and reward: perspectives from three rat models of binge eating.Individual effects of estradiol and progesterone on food intake and body weight in ovariectomized binge rats.Fat emulsion composition alters intake and the effects of baclofen.Baclofen suppresses binge eating of pure fat but not a sugar-rich or sweet-fat diet.Differences in bingeing behavior and cocaine reward following intermittent access to sucrose, glucose or fructose solutions.Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa.Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens.Development of bingeing in rats altered by a small operant requirement.Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trialNeurobiology of consummatory behavior: mechanisms underlying overeating and drug use.Mu opioid receptor antagonism in the nucleus accumbens shell blocks consumption of a preferred sucrose solution in an anticipatory contrast paradigm.Involvement of the endogenous opioid system in the psychopharmacological actions of ethanol: the role of acetaldehyde.Hormonal and neural mechanisms of food reward, eating behaviour and obesity.Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats.Baclofen-induced reductions in optional food intake depend upon food composition.Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model.Effects of lisdexamfetamine in a rat model of binge-eating.A model of binge-like eating behavior in mice that does not require food deprivation or stress.Food Addiction and Binge Eating: Lessons Learned from Animal Models.Activation of Serotonin 2C Receptors in Dopamine Neurons Inhibits Binge-like Eating in Mice.
P2860
Q26996271-992C859F-51D8-41D8-92E7-7DE01260B254Q30440309-1B3C08FC-D9B4-4071-B3BB-E010B25B50AFQ33869522-3DBF1C78-7F95-4C51-9F26-62D37D525CE2Q34284762-6678BAC2-C367-442E-9E49-D58623777DA7Q34296538-FB92CE0E-9465-44F3-B527-18FA63BE0D36Q34486676-11DBBCFB-F7F1-4243-88E2-16ABD75A12BEQ34501087-205FFD85-E945-4B61-B11B-992F9547FD6AQ35093247-B2CCA7F1-22D4-480C-863A-958CA2AD28BAQ35243154-727DB2C1-81EA-43C5-9855-79384F4A40F4Q35549310-D25B99A8-2DF5-4A96-AFEA-D8494A3D936DQ35795667-13C76004-2D62-4D07-978A-75095C9D0AABQ35858513-14E40E33-F529-44F4-877F-C28CAC5F2F91Q36004590-78D6D9F7-8524-441E-9346-9E00A7D2CB30Q36021156-3EA54538-E5E7-4377-9727-36F203B45740Q36249075-C0D5C88C-FB86-48CF-8EBE-3C8EDAF49A2FQ36774139-2F88C831-A814-45F1-9D4B-3DD0693632DDQ37179217-E7B87BA3-8612-4440-9A5D-1191727D8697Q37638007-D2E87BAB-DBFF-416E-96DA-3018206457BEQ37641694-B2F0F1D0-415D-4550-8C75-BFC12C49F3A1Q38126486-21FADAB9-6207-4F37-A12C-CFD33CDD0383Q38222675-F66A790F-72CA-4ABF-BA06-9F9B6DCBD6E4Q39059417-E07388E0-D50E-4F78-A54D-4C6A62DB37E6Q39241226-98B9DE5B-83BE-4BF3-B3D7-9CAA735A3E07Q39773112-58B961D4-A5D5-4EC7-B153-4BAEB239B412Q40295381-B314377D-B743-4A3B-888C-FA8922B10634Q43124454-DDC97A73-2751-41D5-992D-D1BA854D6FF5Q47870177-AB54EA94-3D2C-4217-92DB-77328FEB42EEQ48574951-42C1D95B-1A03-4C2D-AF59-DAFDB7F0308C
P2860
Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Baclofen, raclopride, and nalt ...... der limited access conditions.
@ast
Baclofen, raclopride, and nalt ...... der limited access conditions.
@en
type
label
Baclofen, raclopride, and nalt ...... der limited access conditions.
@ast
Baclofen, raclopride, and nalt ...... der limited access conditions.
@en
prefLabel
Baclofen, raclopride, and nalt ...... der limited access conditions.
@ast
Baclofen, raclopride, and nalt ...... der limited access conditions.
@en
P2093
P2860
P1476
Baclofen, raclopride, and nalt ...... der limited access conditions.
@en
P2093
F H W Wojnicki
R L W Corwin
P2860
P304
P356
10.1016/J.PBB.2009.02.002
P407
P577
2009-02-13T00:00:00Z